Yarrow Bioscience, Inc. lost $31.00 per diluted share in fiscal year 2025. The table below carries 11 fiscal years, from 2015 to 2025, and the quarters Yarrow Bioscience, Inc. has filed alongside them.
FY2025 annual
EPS (Diluted)-$31.00
Ticker history: VYNE became
YARW
(Yarrow Bioscience, Inc.) on .
Earlier news and filings retain their original names and dates.
View VYNE history.
Source SEC FilingsLatest period Q2 FY2026, ended Jun 30, 2026ReportedCurrency USD
Annual figures, oldest first. Point at a bar to read its period.
YARW EPS (Diluted) by Fiscal Year
Figures are in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.
Yarrow Bioscience, Inc. lost $31.00 per diluted share in fiscal year 2025.
Across the 11 fiscal years this page covers, Yarrow Bioscience, Inc. (YARW) diluted earnings per share went from -$3492.00 in fiscal year 2015 to -$31.00 in fiscal year 2025.
Yarrow Bioscience, Inc. (YARW) reported -$3.51 in diluted earnings per share in Q2 2026.
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what Yarrow Bioscience, Inc. (YARW) reported on that line in every period on record.
